[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$f5vmt2AbP_h8Xr8vzz2rpkxevuKrb0GHvwScyY8iLkpQ":8,"$fmTpE8eN5idhIkZcnoHiUYfuryk-GJ1_T3UoxkijdiDI":55,"$fWhwHNbzZkkGxo0F_Hp4egteX-c-IYjTikysGFEpdzp4":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},49820,867252,[],"https://ystcdn.venuertc.com/medical/ystApp/3PMFog9SJLbtP3VML2xGXUy2tMSMprgU.png","曾珊珊","潍坊市益都中心医院","血液内科","住院医师",447,0,"弥漫大B细胞淋巴瘤TP53基因缺失用药安全实用指南","","https://ystcdn.venuertc.com/venue/AI/547c6734-940d-430b-8d5a-ef0052f30859.jpg","\u003Cdiv class=\"guide-wrapper-dlbcl\">\n  \u003Ch2 id=\"material_title\" class=\"guide-title-dlbcl\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">弥漫大B细胞淋巴瘤TP53基因缺失用药安全实用指南\u003C/h2>\n  \u003Cdiv class=\"guide-intro-dlbcl\">\n    说起来针对弥漫大B细胞淋巴瘤TP53基因缺失的药物方案，许多人其实听过一些药名，但对具体用法和安全要点未必清楚。这类药物有严格的使用要求，不同药物之间还可能存在相互作用。今天，我们就来详细说说7个关键细节，每个用药环节都不能大意。\n  \u003C/div>\n\n  \u003C!-- 01 药物种类与核心作用机制 -->\n  \u003Csection class=\"guide-section-dlbcl\">\n    \u003Cdiv class=\"guide-section-title-dlbcl\">\n      \u003Cspan class=\"guide-section-emoji\">💡\u003C/span>\n      \u003Cspan>核心药物类型与作用机制\u003C/span>\n    \u003C/div>\n    \u003Cdiv class=\"guide-section-bg-dlbcl\">\u003C/div>\n    \u003Cdiv class=\"guide-section-content-dlbcl\">\n      用于治疗TP53基因缺失情况下的弥漫大B细胞淋巴瘤，常用药品主要包括：\u003Cbr>\n      \u003Cstrong>1. 烷化剂（如苯达莫司汀）\u003C/strong>——通过破坏肿瘤细胞DNA实现杀伤作用，对细胞有广泛影响。\u003Cbr>\n      \u003Cstrong>2. 来那度胺等免疫调节剂\u003C/strong>——调节人体免疫反应，抑制肿瘤细胞增殖。\u003Cbr>\n      \u003Cstrong>3. 单克隆抗体制剂（如利妥昔单抗）\u003C/strong>——特异性识别并清除异常B细胞。\u003Cbr>\n      \u003Cstrong>4. 靶向药物（如BTK抑制剂、BCL2抑制剂）\u003C/strong>——抑制肿瘤相关信号通路，阻止恶性细胞生长。\u003Cbr>\n      各药物机制不同，有的主要作用于DNA，有的直接影响信号传导。用药选择需个体化，根据治疗阶段调整剂型与组合。\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 02 服药时间和方法要点 -->\n  \u003Csection class=\"guide-section-dlbcl\">\n    \u003Cdiv class=\"guide-section-title-dlbcl\">\n      \u003Cspan class=\"guide-section-emoji\">⌛\u003C/span>\n      \u003Cspan>服药时间和方法细节\u003C/span>\n    \u003C/div>\n    \u003Cdiv class=\"guide-section-bg-dlbcl\">\u003C/div>\n    \u003Cdiv class=\"guide-section-content-dlbcl\">\n      不同药物的服法各有讲究：\u003Cbr>\n      \u003Cstrong>苯达莫司汀\u003C/strong>多为静脉输注，通常每周期按天数分次给药，需严格遵医嘱到院静点，不能自行调整时间。\u003Cbr>\n      \u003Cstrong>来那度胺\u003C/strong>属于口服制剂，最好每日固定时间整片吞服，用水送服，不要嚼碎或压碎。\u003Cbr>\n      \u003Cstrong>利妥昔单抗\u003C/strong>需在医院监护下注射，监测过敏反应，输注前后要补充足够液体。\u003Cbr>\n      \u003Cstrong>服药时可否与食物同服？\u003C/strong> 来那度胺对餐前餐后无强制要求，但最好选在饭后30分钟，减少胃部不适。部分BTK抑制剂空腹或餐后服用效果不同，应按照说明书或医生建议执行。\n      \u003Cbr>\n      \u003Cspan class=\"guide-highlight-dlbcl\">正确做法：\u003C/span> 一定遵照医嘱，不随意更改时间、剂量。如有疑问及时与医生或药师沟通。\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 03 剂型特点与服药技巧 -->\n  \u003Csection class=\"guide-section-dlbcl\">\n    \u003Cdiv class=\"guide-section-title-dlbcl\">\n      \u003Cspan class=\"guide-section-emoji\">💊\u003C/span>\n      \u003Cspan>剂型选择与服药技巧\u003C/span>\n    \u003C/div>\n    \u003Cdiv class=\"guide-section-bg-dlbcl\">\u003C/div>\n    \u003Cdiv class=\"guide-section-content-dlbcl\">\n      \u003Cstrong>静脉制剂\u003C/strong>（苯达莫司汀、利妥昔单抗等）需在医院完成，严禁自行注射。\u003Cbr>\n      \u003Cstrong>口服制剂\u003C/strong>如来那度胺、BTK抑制剂，胶囊/片剂吞服，全片就水，避免破坏缓释、肠溶外衣。一些片剂遇湿易分解，分割保存效果差。\u003Cbr>\n      \u003Cspan class=\"guide-highlight-dlbcl\">饮水量：\u003C/span> 建议服1杯约200ml温水，有助于药物下咽和胃肠道负担减轻。\u003Cbr>\n      如遇吞咽障碍，应咨询药师是否允许掰开、研碎，否则药效和安全难以保证。\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 04 药物相互作用详细说明 -->\n  \u003Csection class=\"guide-section-dlbcl\">\n    \u003Cdiv class=\"guide-section-title-dlbcl\">\n      \u003Cspan class=\"guide-section-emoji\">⚠️\u003C/span>\n      \u003Cspan>药物相互作用\u003C/span>\n    \u003C/div>\n    \u003Cdiv class=\"guide-section-bg-dlbcl\">\u003C/div>\n    \u003Cdiv class=\"guide-section-content-dlbcl\">\n      多种抗肿瘤药合用时，特别要防止不良相互作用：\u003Cbr>\n      \u003Cstrong>苯达莫司汀与CYP1A2抑制剂（如氟西汀等）同用时，血药浓度升高，副作用风险显著增加。\u003C/strong>\u003Cbr>\n      \u003Cstrong>来那度胺与地高辛、华法林共用时\u003C/strong>应加强监测血常规和凝血指标。\u003Cbr>\n      部分BTK抑制剂与抗真菌药（如伊曲康唑）、某些抗生素共用，会加深肝脏负担，甚至导致药物毒性。\u003Cbr>\n      \u003Cspan class=\"guide-highlight-dlbcl\">正确做法：\u003C/span> 开始新药或需合并用药前，提前告知医生近期服用的所有药品（包括中成药及保健品），由专业药师评估风险。\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 05 适应症与禁忌症分开说明 -->\n  \u003Csection class=\"guide-section-dlbcl\">\n    \u003Cdiv class=\"guide-section-title-dlbcl\">\n      \u003Cspan class=\"guide-section-emoji\">🚫\u003C/span>\n      \u003Cspan>适应症与禁忌症说明\u003C/span>\n    \u003C/div>\n    \u003Cdiv class=\"guide-section-bg-dlbcl\">\u003C/div>\n    \u003Cdiv class=\"guide-section-content-dlbcl\">\n      \u003Cstrong>苯达莫司汀\u003C/strong>主要用于特定类型肿瘤的标准治疗方案。\u003Cbr>\n      \u003Cstrong>来那度胺、BTK抑制剂\u003C/strong>适用于相关指南推荐方案。\u003Cbr>\n      \u003Cspan class=\"guide-highlight-dlbcl\">禁忌：\u003C/span> \u003Cstrong>已知对该类药品过敏、高度肝肾功能不全、孕妇和哺乳期妇女、活动性感染未控制者禁用。\u003C/strong>服药期间因个体因素出现严重过敏、骨髓抑制等，应立即停药并就医。\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 06 特殊人群用药调整 -->\n  \u003Csection class=\"guide-section-dlbcl\">\n    \u003Cdiv class=\"guide-section-title-dlbcl\">\n      \u003Cspan class=\"guide-section-emoji\">👨‍👩‍👧‍👦\u003C/span>\n      \u003Cspan>特殊人群用药细节\u003C/span>\n    \u003C/div>\n    \u003Cdiv class=\"guide-section-bg-dlbcl\">\u003C/div>\n    \u003Cdiv class=\"guide-section-content-dlbcl\">\n      \u003Cstrong>老年人、肝肾功能减退者：\u003C/strong> 药物清除速度可能减慢，剂量需适当减少，间隔可拉长，预防毒性反应。\u003Cbr>\n      \u003Cstrong>女性生育期用药：\u003C/strong> 来那度胺及苯达莫司汀类可致胎儿畸形，服药期间和停药后3-6个月内务必避孕。\u003Cbr>\n      \u003Cstrong>肝炎携带者：\u003C/strong> 服用免疫抑制剂时，再激活风险升高，用药前需检查病毒指标并随访肝功能。\u003Cbr>\n      \u003Cspan class=\"guide-highlight-dlbcl\">正确做法：\u003C/span> 特殊人群用药须由临床医生精准评估后方可启动，不可自行调整。\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 07 常见不良反应和处理要点 -->\n  \u003Csection class=\"guide-section-dlbcl\">\n    \u003Cdiv class=\"guide-section-title-dlbcl\">\n      \u003Cspan class=\"guide-section-emoji\">🚨\u003C/span>\n      \u003Cspan>常见不良反应与处理办法\u003C/span>\n    \u003C/div>\n    \u003Cdiv class=\"guide-section-bg-dlbcl\">\u003C/div>\n    \u003Cdiv class=\"guide-section-content-dlbcl\">\n      三类药物各有典型副作用：\u003Cbr>\n      \u003Cstrong>苯达莫司汀\u003C/strong>最常见骨髓抑制，表现为白细胞、血小板减少，易感染或出血。\u003Cbr>\n      \u003Cstrong>来那度胺\u003C/strong>服用期间偶见皮疹、困倦、食欲减退。部分患者可见血栓形成风险增加。\u003Cbr>\n      \u003Cstrong>利妥昔单抗\u003C/strong>主要有输注相关反应，如发热、寒战、皮肤瘙痒等。\u003Cbr>\n      \u003Cspan class=\"guide-highlight-dlbcl\">不适处理：\u003C/span> 出现发热、皮疹、出血点、白细胞突然下降、明显乏力等，应暂停用药并尽快到医院复查血象。\n      \u003Cbr>\n      \u003Cspan class=\"guide-highlight-dlbcl\">临床案例：\u003C/span>\n      \u003Cdiv class=\"guide-case-dlbcl\">\n        临床上一位女性患者接受苯达莫司汀联合免疫调节药方案后，曾因骨髓抑制出现严重粒细胞及血小板减少。调整支持治疗后，白细胞和血小板逐步恢复，因此血象监测是整个治疗周期的关键环节。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 08 储存条件与失效处理 -->\n  \u003Csection class=\"guide-section-dlbcl\">\n    \u003Cdiv class=\"guide-section-title-dlbcl\">\n      \u003Cspan class=\"guide-section-emoji\">📦\u003C/span>\n      \u003Cspan>药品储存条件及过期处理\u003C/span>\n    \u003C/div>\n    \u003Cdiv class=\"guide-section-bg-dlbcl\">\u003C/div>\n    \u003Cdiv class=\"guide-section-content-dlbcl\">\n      \u003Cstrong>苯达莫司汀粉针剂\u003C/strong>应密封避光、2-8℃冷藏保存，使用前15分钟内稀释。\u003Cbr>\n      \u003Cstrong>口服片剂如来那度胺\u003C/strong>需干燥阴凉（不超过25℃）、避免阳光直射。每次取药后立即拧紧瓶盖。\u003Cbr>\n      \u003Cspan class=\"guide-highlight-dlbcl\">过期处理：\u003C/span> 过期变色、潮解、剂型破损的药品严禁继续使用，应交回医院药房或专业回收点，不可随意丢弃以免污染环境。\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 09 漏服与过量处理 -->\n  \u003Csection class=\"guide-section-dlbcl\">\n    \u003Cdiv class=\"guide-section-title-dlbcl\">\n      \u003Cspan class=\"guide-section-emoji\">⏰\u003C/span>\n      \u003Cspan>漏服与过量应对措施\u003C/span>\n    \u003C/div>\n    \u003Cdiv class=\"guide-section-bg-dlbcl\">\u003C/div>\n    \u003Cdiv class=\"guide-section-content-dlbcl\">\n      \u003Cstrong>漏服：\u003C/strong> 若已过计划时间不足12小时，可尽快补服；过12小时则跳过，切勿双倍补服。\u003Cbr>\n      \u003Cstrong>过量服用：\u003C/strong> 有中毒风险，如恶心、呕吐、神志改变等，须立即就医。\u003Cbr>\n      \u003Cspan class=\"guide-highlight-dlbcl\">正确做法：\u003C/span> 建议固定服药时间，用药小本记日志，每次服药打勾，避免遗漏混用。\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 10 真实数据支持与文献引用 -->\n  \u003Csection class=\"guide-section-dlbcl\">\n    \u003Cdiv class=\"guide-section-title-dlbcl\">\n      \u003Cspan class=\"guide-section-emoji\">📑\u003C/span>\n      \u003Cspan>数据支持与参考文献\u003C/span>\n    \u003C/div>\n    \u003Cdiv class=\"guide-section-bg-dlbcl\">\u003C/div>\n    \u003Cdiv class=\"guide-section-content-dlbcl\">\n      \u003Cstrong>数据一则：\u003C/strong> 根据一项回顾性研究，来那度胺相关中性粒细胞减少发生率约21%，BTK抑制剂引起的消化道反应发生率约10%\u003Csup>1\u003C/sup>。\u003Cbr>\n      \u003Cstrong>数据二则：\u003C/strong> 苯达莫司汀相关输注反应发生率在5%-12%之间，多在输注首日出现，后续递减\u003Csup>2\u003C/sup>。\n      \u003Col class=\"guide-references-dlbcl\">\n        \u003Cli>\n          Wang, M., Fowler, N., Wagner-Bartak, N., et al. (2017). Safety and Efficacy of Combination Therapy With Lenalidomide, Bendamustine, and Rituximab in Patients With Relapsed and Refractory B-cell Non-Hodgkin Lymphoma. \u003Ci>Haematologica\u003C/i>, 102(10), 1788-1794.\n        \u003C/li>\n        \u003Cli>\n          Cheson, B.D., Rummel, M.J., Van der Jagt, R.H., et al. (2010). Bendamustine-Rituximab Combination Therapy in Patients With Non-Hodgkin Lymphoma: A Multicentre, Randomised Phase III Study. \u003Ci>The Lancet\u003C/i>, 375(9718), 1376-1384.\n        \u003C/li>\n      \u003C/ol>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 11 总结与安全用药提醒 -->\n  \u003Csection class=\"guide-section-dlbcl\">\n    \u003Cdiv class=\"guide-section-title-dlbcl\">\n      \u003Cspan class=\"guide-section-emoji\">📝\u003C/span>\n      \u003Cspan>安全用药总结随手记\u003C/span>\n    \u003C/div>\n    \u003Cdiv class=\"guide-section-bg-dlbcl\">\u003C/div>\n    \u003Cdiv class=\"guide-section-content-dlbcl guide-summary-dlbcl\">\n      总之，这类药品在治疗过程中药效明确，但每一步操作都关系到疗效和安全平衡。尤其是骨髓抑制、相互作用和剂量遵守方面，不能有任何侥幸。再次特别提醒：\u003Cbr>\n      \u003Cspan class=\"guide-summary-bullet-dlbcl\">🟢\u003C/span> \u003Cstrong>用药严格依照医嘱，每周期监控血象变化，定期检验安全指标。\u003C/strong>\u003Cbr>\n      \u003Cspan class=\"guide-summary-bullet-dlbcl\">🟢\u003C/span> \u003Cstrong>发生不良反应或疑似用药安全隐患，需第一时间就医。\u003C/strong>\u003Cbr>\n      只有科学合理用药，才能防止药害，发挥最大药效。如果遇到疑问，不妨主动寻求药师帮助，让自己的治疗每一步更安心。\n    \u003C/div>\n  \u003C/section>\n\u003C/div>\n\n\u003Cstyle>\n.guide-wrapper-dlbcl {\n  background: #fafbff;\n  border-radius: 16px;\n  max-width: 820px;\n  margin: 36px auto 80px auto;\n  box-shadow: 0 4px 18px rgba(120,145,185,0.06);\n  font-family: \"微软雅黑\", \"Helvetica Neue\", Arial, sans-serif;\n  padding: 32px 24px 48px 24px;\n  color: #262c37;\n  line-height: 2.0;\n}\n.guide-title-dlbcl {\n  color: #1f2c49;\n  font-size: 2.4em;\n  font-weight: bold;\n  margin-bottom: 26px;\n  letter-spacing: 2px;\n  border-left: 6px solid #6286b1;\n  background: linear-gradient(90deg, #e3ecf6 70%, transparent 100%);\n  padding: 10px 0 10px 20px;\n}\n.guide-intro-dlbcl {\n  font-size: 1.10em;\n  margin-bottom: 26px;\n  background: #e9f2fd;\n  border-radius: 8px;\n  padding: 18px 16px;\n}\n.guide-section-dlbcl {\n  margin-bottom: 38px;\n  position: relative;\n  padding-bottom: 2px;\n}\n.guide-section-title-dlbcl {\n  display: flex;\n  align-items: center;\n  font-size: 1.20em;\n  font-weight: bold;\n  background: linear-gradient(90deg,#f7fafd 60%,transparent 100%);\n  padding: 10px 0 10px 18px;\n  border-left: 5px solid #7ea7e4;\n  border-radius: 6px 0 0 6px;\n  z-index: 3;\n  position: relative;\n}\n.guide-section-emoji {\n  font-size: 27px;\n  margin-right: 10px;\n}\n.guide-section-bg-dlbcl {\n  background: linear-gradient(90deg, #eaf2fc 90%, transparent 100%);\n  border-radius: 12px;\n  position: absolute;\n  top: 42px;\n  left: 0;\n  width: 98%;\n  height: 100%;\n  z-index: 0;\n  opacity: 0.44;\n  min-height: 110px;\n  pointer-events: none;\n}\n.guide-section-content-dlbcl {\n  font-size: 1.05em;\n  margin-left: 0;\n  margin-top: 22px;\n  margin-right: 0;\n  position: relative;\n  z-index: 2;\n  padding: 17px 18px 13px 18px;\n  border-radius: 8px;\n  background: rgba(249,250,255,0.83);\n  box-shadow: 0 2px 7px rgba(120,145,185,.03);\n}\n\n.guide-highlight-dlbcl {\n  background: #c6e4fd;\n  color: #1f3f7c;\n  font-weight: bold;\n  border-radius: 3px;\n  margin-right: 2px;\n  padding: 1px 5px;\n}\n.guide-case-dlbcl {\n  border-left: 4px solid #6fbdfa;\n  background: #f0fbfd;\n  color: #316d85;\n  margin: 12px 0 4px 0;\n  padding: 8px 17px 8px 12px;\n  font-size: 1em;\n  border-radius: 0 6px 6px 0;\n}\n\n.guide-references-dlbcl {\n  margin: 17px 0 0 18px;\n  color: #51618a;\n  font-size: 0.98em;\n}\n.guide-references-dlbcl li {\n  margin-bottom: 7px;\n  padding-left: 0;\n}\n\n.guide-summary-dlbcl {\n  background: #f2f7fa;\n  font-weight: normal;\n  color: #21334a;\n  border-radius: 10px;\n  margin-top: 14px;\n  box-shadow: none;\n  font-size: 1.08em;\n}\n.guide-summary-bullet-dlbcl {\n  color: #5788c0;\n  font-size: 1.2em;\n  margin-right: 4px;\n}\n@media screen and (max-width: 600px) {\n  .guide-wrapper-dlbcl {padding: 7px 1px 34px 1px;}\n  .guide-title-dlbcl {font-size: 1.5em; padding-left: 9px;}\n  .guide-section-dlbcl {margin-bottom: 20px;}\n  .guide-section-content-dlbcl {padding: 9px 6px 6px 7px;}\n  .guide-section-title-dlbcl {padding-left: 7px;}\n  .guide-case-dlbcl {padding: 7px 6px 7px 6px;}\n}\n\u003C/style>\n","\u003Cdiv class=\"guide-wrapper-dlbcl\">\n  \u003Ch2 id=\"material_title\" class=\"guide-title-dlbcl\" style=\"color: ",516,"2025-07-17 11:56:06","弥漫大B细胞淋巴瘤, TP53基因缺失, 药物安全, 免疫调节剂, 烷化剂, 骨髓抑制, 不良反应, 特殊人群用药","本指南详细介绍弥漫大B细胞淋巴瘤TP53基因缺失的安全用药方案，包括药物机制、用法、相互作用、禁忌症等，确保患者治疗安全。","2025-07-22 16:28:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]